REENU SAJAN: Open Payments
NPI 1295492650 · CEDAR PARK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 9 payments from 7 companies in 2025. Trend: 2023 $299 · 2024 $641 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Viatris Specialty LLC | 1 | $30 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: DUPIXENT, INSPIRE, YUPELRI, NEFFY, AIRSUPRA, Rhapsido, TEZSPIRE, NUCALA.
Industry payments across TX — which companies pay providers there.
